eng Science and Education Publishing American Journal of Medical Case Reports 2374-216X 2015-08-28 3 9 301 303 10.12691/ajmcr-3-9-10 AJMCR20153910 article Ilknur NIZAM ilknizam@yahoo.com 1 Mehmet Ali Erkurt 2 Ilhami Berber 2 Emin Kaya 2 Irfan Kuku 2 Mustafa Koroglu 3 Department of Internal Medicine, Faculty of Medicine, Inonu University, Malatya, TURKEY Turgut Ozal Medical Center Karabuk Education and Research Hospital Immune trombocytopenia is an autoimmune disease characterised by abnormal platelet destruction. Corticosteroids and intravenous immune globulin are main first line treatment options. Splenectomy is a preferred second line treatment option for unresponsive patients at many centers. Secondary thrombocytosis is a possible complication awaiting this group of patients after splenectomy. Here, we present a case of myocardial infarction at a patient who had undergone splenectomy for ITP, which is a rare event seen with secondary thrombocytosis due to splenectomy. http://pubs.sciepub.com/ajmcr/3/9/10/ajmcr-3-9-10.pdf immune thrombocytopenia splenectomy myocardial infarction